Sugi 30670
Ref 30670
Sugi 30670 is a device classified as Class I in the EU and Class II in the US made by QuestAlpha GmbH & Co. KG, registered in EUDAMED on 21 May 2025 (Basic UDI-DI 426030671NONST8D) and listed in FDA GUDID since 6 Sep 2019 (UDI-DI 04260306710416), active as of 25 Oct 2026.
Active
CE MDR
Valid until
No date given
FDA recalls
Not checked
Documents
None, self-declared
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR EUDAMED | Number426030671NONST8D 04260306710416 | Date21 May 2025 | StatusActive |
| United States | GUDID listing GUDID | Number04260306710416 | Date6 Sep 2019 | StatusListed |
Official records
- EUDAMED public site 426030671NONST8D
- AccessGUDID record 04260306710416
Across registries
- EUDAMED Basic UDI-DI 426030671NONST8D registered 21 May 2025 Active
- FDA GUDID UDI-DI 04260306710416 listed 6 Sep 2019 Listed
Certificates
No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.
Timeline
- Listed FDA GUDID 04260306710416
- Registered EUDAMED 426030671NONST8D
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Sugi iSpear (pointed tip), round light blue handle, non-sterile, 500 x 6 pcs. EUDAMEDSugi GUDID
- Generic name
- Ophthalmic sponge
- Device name
- Sugi Eyespear (pointed tip), non-sterile, 17 x 7mm, 20 x 10 pcs.
- Model / Ref / Catalog
- 30670
- Primary DI / UDI-DI
- 04260306710416
- Basic UDI-DI
- 426030671NONST8D
- Direct marketing DI
- 04260306710416
- FDA product code
- HOZ
- EMDN code
- M040299 Non-adhesive absorbent dressings - other
- GMDN term
- Ophthalmic sponge
- Device class
- Class I EUDAMEDClass II GUDID
- Regulation number
- 886.4790
- EU registration type
- Standard device
- EU market of registration
- Germany
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class I | Class II |
| Sterilise before use | Yes | No |